chr4-372888-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_003441.4(ZNF141):c.451G>A(p.Val151Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,548 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_003441.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF141 | NM_003441.4 | c.451G>A | p.Val151Ile | missense_variant | 4/4 | ENST00000240499.8 | NP_003432.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF141 | ENST00000240499.8 | c.451G>A | p.Val151Ile | missense_variant | 4/4 | 1 | NM_003441.4 | ENSP00000240499.7 | ||
ZNF141 | ENST00000512994.5 | c.451G>A | p.Val151Ile | missense_variant | 4/5 | 1 | ENSP00000425799.1 | |||
ZNF141 | ENST00000505939.5 | c.227-10207G>A | intron_variant | 5 | ENSP00000424403.1 | |||||
ZNF141 | ENST00000366506.4 | n.398G>A | non_coding_transcript_exon_variant | 2/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000148 AC: 37AN: 250812Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135608
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461206Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 726856
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74506
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at